Ontario Institute for Cancer Research

Identification of human brain tumour initiating cells

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.

The landscape of somatic copy-number alteration across human cancers

The repertoire of mutational signatures in human cancer

International network of cancer genome projects

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy of unknown genetic basis. We performed whole-genome sequencing of 12 ETP ALL cases and...

Photo-Induced Peptide Cleavage in the Green-to-Red Conversion of a Fluorescent Protein

Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group

Objective To present findings of a narrative review on the implementation and effectiveness of 17 Articles of the WHO Framework Convention on Tobacco Control (FCTC) during the T...

Molecular profiling of breast cancer: portraits but not physiognomy.

Breast cancers differ in response to treatment and may have a divergent clinical course despite having a similar histopathological appearance. New technology using DNA microarra...